1 / 72

Electerical Injery and other Rays to the eyes

Electerical Injery and other Rays to the eyes. A.Hekmatian MD 1387. Electric shock0. a. Very rare cause of cataract, 5% to 20% major electrical injury patients. b. Most often follows shock to head. c. Usually more than 1,000-V current.

suchin
Download Presentation

Electerical Injery and other Rays to the eyes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Electerical Injery and other Rays to the eyes A.Hekmatian MD 1387

  2. Electric shock0 a. Very rare cause of cataract, 5% to 20% major electrical injury patients. b. Most often follows shock to head. c. Usually more than 1,000-V current. d. Initial anterior cortical vacuoles, replaced by white opacities. e. PSCcataract less common. f. Cataract may present many months after injury. g. Cataract matures within few years after injury.

  3. What are ultraviolet rays? Ultraviolet (UV) rays are part of electro-magnetic radiation. They are invisible rays lying beyond the violet end of the visible spectrum. Low intensity ofUV rays are also emitted from fluorescent lamps, TV and computer monitors.

  4. Are there different types of UV rays? As different intensity (wavelength) ofUV has different effect on us, they are commonly categorized as UV-A, UV-B and UV-c. UV-C (wavelengths from 200nm - 290nm) is present above the earth's atmosphere and also given out from welding arcs. It also arises from sunlight's reflection from snow at high altitude. UV-B (wavelengths from 290nm - 320nm) and UV-A (wavelengths from 320nm - 390nm) are present in our living environment, from direct sunlight or reflection from snow, water, sands, glass windows, walls etc

  5. Ultraviolet Radiation Inju I. Clinical features A. Synonyms. 1. Snowblindness. 2. Welder's arc burn. 3. Keratitis photoelectrica. 4. Ultraviolet (UV) keratopathy) B. Ocular features. 1. Onset of symptoms usually 8 to 24 hours after exposure and characterized by pain, photophobia, and foreign body sensation.

  6. 2. Signs may include eyelid erythema; tearing,conjunctival injection, corneal epithelial irregularities, edema, and punctate epithelial erosions.

  7. C. Course/prognosis. 1. Signs and symptoms should resolve over 24 to 48 hours. 2. Prognosis for visual recovery is excellent. 3. Chronic UV exposure can lead to pterygia, pingueculae, an cataracts. D. Complications/sequelae. 1. Any breakdown of corneal epithelium causes eye to be more susceptible to infection, ulceration, and scarring. 2. Also, association exists with conjunctival squamous cell carcinoma.

  8. A. Pathogenesis 1. Clinical findings result from excessive exposure to radiation with wavelength of approximately 290 nm. 2. Exposure to UV radiation results in characteristic changes in cells produced by changes in proteins, including inhibition of mitosis and loss of cellular adhesion. 3. Clinical and pathologic changes evident after 6 to 8 hours of , exposure.

  9. B. Risk factors 1. Physical factors. a. Snow can reflect UV light, welder's lamps, and othersources such as sunlamps, malfunctioning mercury vapor lamps 2. Iatrogenic factors phototherapy for psoriasis or other medical conditions can cause keratopathy. 3. Use of tanning bed without protective goggles increases risk. C. Epidemiology. 1. Fairly common, especially among welders.

  10. Diagnosis A. Slitlamp examination with instillationof fluorescein reveals typical punctate epithelial changes. B. Palthologic findings. 1. uv waves generally absorbed by conjunctiva and cornea, 'leading to conjunctivitis and keratitis. C. Differential diagnosis 1. Other causes of punctate staining include dry eye (keratoconjunctivitis sicca), floppy eyelid syndrome

  11. Management/treatment A. Oral alnalgesics and pressure patching with antibiotic ointment .Bandage contact lenses also aid with healing B. Consider treating as corneal abrasion if significant number of punctate epithelial erosiqns present. C. Preventionl avoidance . 1. Use UV-absorbing glasses or goggles and proper eyewear when welding to prevent this condition,

  12. D. Monitoring 1. Follow up patients every few days until corneal epithelial defect resolved. E. Patient education 1. Signs and symptoms generally resolve in 24 to 48 hours. 2. Remind patient to use UV-protective eyewear.

  13. Radiation Retinopathy I. Clinical features A.Clinical description. 1. Findings resemble diabetic retinopathy. B. Signs and symptoms. 1. Reduced visual acuity secondary to macular edema and non perfusion occurs 6 to 36 months after treatment.

  14. 2.Bilateral in one third of.external beam irradiation cases. 3. Early features. a. Microaneurysms. b. Telengiectasia. c. Cotton-wool spots. d. Intraretinal hemorrhages. e. Capillary non perfusion. - f. Retinal edema. g. Hard exudates.

  15. Microaneurysmal changes telangiectasias Edema ; andhemorrhages are temporal to the fovea in OS

  16. 4.Late features. a. Vascular sheathing. b. Hard exudates. c. Cystoid macular edema. d. Neovascularization. e. Rubeosis and neovascular glaucoma. f. Ischemic optic neuropathy.

  17. Basics A.Pathogenesis. 1. On retinal vascular endothelial cellular level, mitosis arrested and nucleus may degenerate. 2. Initial vascular changes include early swelling with degeneration of intima and endothelial cells. 3. Subsequent changes include vascular occlusion by thrombus formation and fibrosis.

  18. B. Risk factors 1. Neoplasm involving eye, orbital, periorbital, nasopharyngeal, face, brain, or other adjacent tissue, with subsequent irradiation and inadequate shielding by technical staff. a. Fifty percent of patients treated for nonocular neoplasm.

  19. 2. Radiation retinopathy develops after total doses of 30 to 35 Gy within 3 to 36 months (mean time, 18 months). a. If more than 80 Gy administered, 85% of patients develop radiation retinopathy within few months.

  20. 3. Higher the fraction size, greater the risk of radiation retinopathy. a. Usual dose for external beam therapy 200 to 300 cGy/day, given over 1- to 2-month period for total dose of 35 to 72 Gy. b. Twice as many patients develop radiation retinopathy with 250-cGy fractions than with 200-cGy fractions.

  21. 4. Local plaque therapy (brachytherapy) requires higher doses to produce damage than external beam therapy(teletherapy). 5. Diabetes mellitus and administration of chemotherapy, whether concomitant or not, additive to retinopathic effects of radiation.

  22. Diagnosis A. Clinical diagnosis. 1. Consider when head or neck radiation given for any reason including metastatic CNS tumors, orbital treatment for thyroid disease, and orbital pseudotumor.

  23. B. Imaging 1. Fluorescein angiographyshows capillary nonperfusion. A.Early phase (1) Dilated and telangiectatic retinal vessels. (2) Blocked fluorescence secondary to retinal hemorrhages.

  24. (3) Hypofluorescence secondary to capillary nonperfusion. b.laet phase (1) Leakage from affected retinal vessels and from neovascularization if present C. Pathologic findings. 1. Preferential damage to inner retinal layers resulting in paucity of ganglion cells. Photo receptors relatively resistant.

  25. Fluorescein angiogram of the left eye demonstrates large areas of capillary nonperfusion. The foveal avascular zone is enlarged, and the microaneurysms show leakage.

  26. 2. Eosinophilic exudate in outer • plexiform layers. 3. Retinal capillary changes • including fusiform dilations, • microaneurysms, and focal loss • of endothelial cells and • pericytes. 4. Capillary closure

  27. 5. Thickening of retinal blood vessel walls. 6. New blood vessels on surface of retina or optic disc. 7. Intraretinal blood or blood in vitreous cavity. 8. Peripheral anterior synechiae and fibrovascular membrane on surface of iris in eyes with neovascular glaucoma.

  28. D. Differential diagnosis. 1. Diabetic retinopathy. 2. Multiple branch retinal artery obstruction and embolic disease. 3. Multiple episodes of venous occlusive disease.

  29. 4.Postoperative cystoid macular edema. 5. Sickle cell disease. 6.Peripheral uveitis. 7. Hypertension. 8. Ocular ischemic syndromes. 9. Takayasu disease. 10. Hyperviscosity syndromes and blood dyscrasias.

  30. Managementltreatment A. Medical therapy. 1. Apply guidelines of Early . Treatment Diabetic Retinopatpy Study for macular edema and neovascularization.

  31. 2. Macular photocoagulation effective in decreasing macular edema; may improve vision. 3. Consider pars plana vitrectomy for nonclearing vitreous hemorrhage.

  32. B. Prevention. 1. Adequate shielding of eye during radiation treatment. 2. If satisfactory shielding not achieved, patient will receive far larger dose than prescribed by radiation oncologist . 3. Inadequate shielding considered responsible for cases of retinopathy after radiation thought of safe dose or in area thought to pose no threat to ocular tissue .

  33. C. Monitoring. 1. Monitor frequently for development of retinal changes.

  34. Solar Retinopathy I. Clinical features A. Synonyms. 1. Solar retinopathy. 2. Eclipse burn. 3. Eclipse blindness. 4. Eclipse retinopathy. 5. Solar retinitis. 6. Solar chorioretinal burn. 7. Photoretinitis. 8. Foveomacular retinitis.

  35. B. Clinical description. 1. Signs and symptoms. a. Initial features. (1) Browache. (2) Positive central scotoma. (3) Afterimage. (4) Chromotopsia. (5) Metamorphopsia (6) Decreased visual acuity, usually to 20/200 level. (7) Small, yellow-grayish

  36. b. Chronic features (1) Yellow-grayish lesion fades over 2 weeks; replaced by "lamellar hole" or "cyst,“ which produces permanent red foveal appearance. Red reflex permanent and pathognomonic. (2) Foveolar depression. (3) Macular pigmentary disruption can occur with significant solar phototoxicity

  37. b. Chronic features Yellowish pigment epithelial lesions are seen in the fovea. The OS demonstrates a yellowish lesion at the level of the retinal pigment epithelium centered on the fovea.

  38. Two months later the yellowish lesion has been replaced by a small, focal depression. Fluorescein angiogram demonstrates a Centra window defect in the macula.

  39. Basics A. Pathogenesis. 1. Blue light largely responsible for producing photochemical injury by initially damaging apical melanosomes in retinal pigment. 2. Subsequent release of lysosomal enzymes may occur, with resultant cell damage and degeneration of photoreceptors and RPE.

  40. B. Risk factors. 1. Sun gazing. a. Illicit drug use. b. Viewing solar eclipse c. Occupational (ie, astronomers, military personnel).

  41. 2. Without sun gazing. a. Increased ocular pigmentation. b. Increased body temperature,warm climate, exercise, or infection. c. Clear ocular media d. Environmental conditions such as highly reflective surroundings and reduced atmospheric ozone.

  42. Diagnosis A. Imaging. 1. Fluorescein angiography. a. In early stages, leakage of dye occurs through RPE;clinically may appear as yelloWish abnormality seen in fovea· b. In severe cases, window defect may be present.

  43. The right macula reveals an abnormal foveal reflex with a small reddish facet-like eccentric defect within the fovea. Fluorescein angiogram demonstrates a verysubtle window defect centered on the fovea.

  44. B. Pathologic findings. 1. Focal loss of rod and cone nuclei. 2. Disruption of receptor elements in foveola. 3. In severe cases. RPE depigmented but intact. 4. Choriocapillaris intact.

More Related